Immunomodulation with Recombinant Interferon-γ1b in Pulmonary Tuberculosis

BACKGROUND: Current treatment regimens for pulmonary tuberculosis require at least 6 months of therapy. Immune adjuvant therapy with recombinant interferon-γ1b (rIFN-γb) may reduce pulmonary inflammation and reduce the period of infectivity by promoting earlier sputum clearance. METHODOLOGY/PRINCIPA...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Dawson, Rod, Condos, Rany, Tse, Doris, Huie, Maryann L., Ress, Stanley, Tseng, Chi-Hong, Brauns, Clint, Weiden, Michael, Hoshino, Yoshihiko, Bateman, Eric, Rom, William N.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Public Library of Science 2009
Onderwerpen:
Research Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2737621/
https://ncbi.nlm.nih.gov/pubmed/19753300
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0006984
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items